These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7985689)

  • 1. Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
    Hassan E; Leslie J; Martir-Herrero ML
    Am J Hosp Pharm; 1994 Sep; 51(17):2143-5. PubMed ID: 7985689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
    Burm JP; Jhee SS; Chin A; Moon YS; Jeong E; Nii L; Fox JL; Gill MA
    Am J Hosp Pharm; 1994 May; 51(9):1201-4. PubMed ID: 7913797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    Am J Hosp Pharm; 1992 Nov; 49(11):2769-72. PubMed ID: 1471644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility and stability of labetalol hydrochloride in commonly used intravenous solutions.
    Yuen PH; Taddei CR; Wyka BE; Chaudry IA
    Am J Hosp Pharm; 1983 Jun; 40(6):1007-9. PubMed ID: 6869384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of dobutamine hydrochloride in peritoneal dialysis solutions.
    Gora ML; Seth S; Visconti JA; Shields B; Bay W
    Am J Hosp Pharm; 1991 Jun; 48(6):1234-7. PubMed ID: 1858802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of dopamine hydrochloride injection in the presence of dobutamine hydrochloride, tolazoline hydrochloride, and theophylline injections.
    Bhatt-Mehta V; Nahata MC
    J Perinatol; 1990 Jun; 10(2):129-33. PubMed ID: 2358894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
    Woloschuk DM; Wermeling JR; Pruemer JM
    Am J Hosp Pharm; 1991 Oct; 48(10):2158-60. PubMed ID: 1781472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
    Lam XM; Ward CA; du Mée CP
    Am J Health Syst Pharm; 1995 Sep; 52(17):1904-9. PubMed ID: 8528854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.
    Bullock L; Parks RB; Lampasona V; Mullins RE
    Am J Hosp Pharm; 1985 Dec; 42(12):2683-7. PubMed ID: 3936354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs.
    Bergquist PA; Manas D; Hunke WA; Reed RA
    Am J Health Syst Pharm; 2001 Jul; 58(13):1218-23. PubMed ID: 11449879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of dobutamine hydrochloride in selected large-volume parenterals.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
    Trissel LA; Bready BB
    Am J Hosp Pharm; 1992 Jul; 49(7):1716-9. PubMed ID: 1352424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride.
    Walker SE; DeAngelis C; Iazzetta J; Eppel JG
    Am J Hosp Pharm; 1991 Oct; 48(10):2161-6. PubMed ID: 1723578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.